SMT D002 is a medication which has potential for use as an acne treatment. In pill form it has reportedly proved very successful at reducing sebum production during clinical trials carried out by UK-based drug discovery company Summit Corporation PLC (AIM: SUMM). It is claimed to be safer than isotretinoin, which is currently the only medication accepted by the medical profession as being an effective sebosuppressive.
It has been referred to as a 'cure for acne' by the press. In fact it could not accurately be referred to as a cure, but at best an effective preventive treatment.
Read more about SMT D002: Origin, Clinical Trials, Future Development